Congress news
ESMO World congress on Gastrointestinal cancer
The ESMO World congress on Gastrointestinal cancer will be held in Barcelona, Spain, from 3rd to 6th July 2019.
In addition to key study details including FOLRIRI/FOLFOX and REARRANGE, the event will present the following press releases:
- Greater awareness needed of stomach cancer risk in under-40s, especially in Latin America (Abstract P-145), under embargo until Tuesday, 2 July 2019 at 8:00 CEST
- Randomised trial identifies optimal regimen of total neoadjuvant therapy for rectal cancer (Abstract O 011), under embargo until Thursday, 4 July 2019 at 9:30 CEST
- Targeted therapy combination improves survival in patients with advanced bowel cancer (Abstract LBA 006), under embargo until Saturday, 6 July 2019 at 11:00
- New trial demonstrates the efficacy of a more flexible dose of regorafenib to relieve side-effects in patients with metastatic colon cancer (Abstract O-026), under embargo until Saturday, 6 July 2019 at 11:00 CEST
Further details from the ESMO World Congress on Gastrointestinal Cancer can be found here.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
